Acceleron Pharma
XLRN
#1558
Rank
โ‚ฌ9.62 B
Marketcap
157,44ย โ‚ฌ
Share price
0.00%
Change (1 day)
14,176.45%
Change (1 year)

Revenue for Acceleron Pharma (XLRN)

Revenue in 2021 (TTM): โ‚ฌ95.1 Million

According to Acceleron Pharma's latest financial reports the company's current revenue is โ‚ฌ99.32 Million. In 2020 the company made a revenue of โ‚ฌ81.49 Million an increase over the revenue in the year 2019 that were of โ‚ฌ65.17 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Acceleron Pharma from 2012 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ95.1 M16.7%
2020โ‚ฌ81.49 M25.05%
2019โ‚ฌ65.17 M428.85%
2018โ‚ฌ12.32 M3.78%
2017โ‚ฌ11.87 M-51.45%
2016โ‚ฌ24.45 M53.47%
2015โ‚ฌ15.93 M23.68%
2014โ‚ฌ12.88 M-74.43%
2013โ‚ฌ50.4 M275.17%
2012โ‚ฌ13.43 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ29.43 B 29,540.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ12.50 B 12,494.45%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ78.23 B 78,667.16%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.19 M-99.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ50.91 M-48.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ73.81 M-25.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ56.04 B 56,324.04%๐Ÿ‡บ๐Ÿ‡ธ USA